在有抑郁症状和没有抑郁症状的患者之间,与失眠症状相关的因素的差异
Sang-Ahm Lee1, Eun Ju Choi1, Hyun-Woo Kim1
1Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Epilepsy & behavior : E&B
|May 24, 2024
概括
患者的失眠因素因抑郁症而异. 失控的发作和白天的嗜睡与没有抑郁症的人的失眠有关,而女性的性行为与抑郁症的人有关.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
背景情况:
- 是一种神经系统疾病,通常与睡眠障碍和抑郁症并发.
- 了解,抑郁和失眠之间的相互作用对于全面的患者护理至关重要.
研究的目的:
- 为了调查与失眠症状相关的因素是否在患者与并发性抑郁症状之间有所不同.
- 在这些不同的患者群体中确定失眠的特定预测因素.
主要方法:
- 一项涉及282名患有的成年人的跨界多中心研究.
- 收集的数据包括抑郁症状 (患者健康问卷-9,PHQ-9 ≥10),失眠症状 (失眠严重程度指数,ISI ≥15) 和过度的白天嗜睡 (爱普沃思嗜睡量表,ESS ≥11).
- 后勤回归分析,包括相互作用术语,用于根据抑郁状态识别不同的失眠相关因素.
主要成果:
- 23.4%的患者有抑郁症状,20.2%有失眠症状,12.8%有过度的白天嗜睡.
- 患有抑郁症的患者报告失眠症状的可能性明显增加 (56.1%对比9.3%).
- 在没有抑郁症的患者中,失控的发作,白天嗜睡和精神疾病史与失眠有关. 在患有抑郁症的患者中,女性的性别与失眠有关,而佩拉曼尼尔的使用则相反地相关.
结论:
- 导致患者失眠的因素因抑郁症的存在或不存在而有很大差异.
- 这些发现凸显了针对症失眠的量身定制管理策略的需要,考虑到个人的抑郁状态.
- 认识到这些独特的关联可以改善和并发性睡眠和情绪障碍患者的临床管理.
更多相关视频
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
5.4K
09:06Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
9.6K
相关概念视频
01:27Insomnia
82
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
82
01:14CNS Depressants: Barbiturates and Benzodiazepines
250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250
01:13Insufficient Sleep and Sleep Deprivation
139
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
139
01:18Depression: Overview
238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244